THE isolation by King in 1934 of the active principle from curare initiated the use of muscle relaxants in anaesthesia. Since that time there have been many attempts to prepare synthetic muscle relaxants, including the preparation and study of the methonium compounds. Of the methonium series, decamethonium salts showed sufficient promise to be tested in man and finally became established as a useful muscle relaxant for use in surgical anesthesia and convulsion therapy. This paper will deal with the changes in form and amount of the electrical activity of intact human voluntary muscles which occur when decamethonium iodide (C 10) is given intravenously. Particular reference will be made to the effect of blood flow on the duration of action of this drug and the remarkable tolerance of patients suffering from myasthenia gravis to its action.
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ACTION OF DECAMETHONIUM IODIDE
It has been established by , Buttle and Zaimis (1949) , Zaimis (1951) , Brown, Paton and Vianna Das (1949) and more recently by Burns and Paton (1951) that decamethonium salts produce muscle relaxation in a way fundamentally different from that of curare and in fact have an action similar to that of acetylcholine. Dale, Feldberg and Vogt (1936) showed that the stimulus of contraction from motor nerve to voluntary muscle takes place by the release of acetylcholine at the nerve endings. The function of this acetylcholine is to excite the motor end-plate and initiate muscle contraction. This excitation is short-lived, because acetylcholine is -rapidly destroyed by cholinesterases in the muscle, but it can be identified by the simultaneous electrical changes which give rise to the action potential associated with muscle contraction. The electrical changes accompanying excitation are referred to as depolarization. Similar changes are produced by decamethonium iodide, but since this substance is not rapidly destroyed, they are prolonged. Thus, following the initial brief muscle contraction accompanying depolarization, the muscle fibre is unable to respond to further nerve impulses until it regains its original state. In fact, a condition of neuromuscular block is produced. All this is in contrast to curare which raises the. threshold of the motor end-plate for acetylcholine, thus preventing depolarization taking place.
METHODS OF ASSESSING THE EFFECTS OF MUSCLE RELAXANTS (a) Mechanical methods.-Previous investigations on human subjects with decamethonium iodide have generally been made by mechanical methods alone; the apparatus used being variously referred to as a dynamometer or an ergometer. For the sake of uniformity throughout this paper the term ergometer will be used. Thus Guild (1950) measured grip strength with a mercury column ergometer while Unna et al. (1950) used spring ergometers.
(b) Electromyographic methods.-When muscle fibres contract in response to nerve impulses, the phenomenon of depolarization spreads along the fibre giving rise to a propagated action potential which may be studied by electromyography. In the investigation of neuromuscular diseases electromyography is used in two ways. First, to study the dimensions of single muscle action potentials from which may be determined the site of pathological lesions and second, to measure the total electrical discharge of a muscle which may be used as an index of the number of contracting muscle fibres stimulated in various ways. These quantitative measurements may be used, for instance, to measure neuromuscular transmission in myasthenia gravis and to follow the course of peripheral nerve injuries. They may similarly be used to study the action of muscle relaxants.
Electromyographic techniques have advantages over techniques based on mechanical methods. Apart from the portability of electromyographic equipment which makes it easy to use in the operating theatre, measurements from a single muscle can be readily obtained. Further, whereas measurements of muscle power by ergometers demand a full volitional effort on the part of the subject, a matter of some difficulty when muscle relaxants are administered to myasthenics, with the electromyographic technique a supramaximal electrical stimulus can be supplied to the peripheral nerve. This allows its use even in unconscious subjects. The supramaximal nerve stimulus may, of course, be delivered at various rates and therefore the degree of neuromuscular block with muscle twitch and tetanus may be determined.
APRIL-ANEsSTH. 1 The muscle contraction produced by electrical stimulation of a motor nerve is, however, different from that produced by a voluntary contraction. The functional unit of normal muscle is the motor unit which is defined as the ventral horn or motor nerve cell and the group of muscle fibres it supplies. It follows that the discharge of a single motor neurone brings about the almost simultaneous contraction of the hundred or so muscle fibres that are supplied by this neurone. Maximal voluntary contraction invokes the activity of many of these motor units acting asynchronously at an average maximum rate of 20 per second; this graded activity of motor units provides for the smooth contraction of muscle. In contrast, electrical simulation of the nerve produces a synchronous discharge of all the motor units. This difference is, however, irrelevant to comparative measurements of muscle power during the administration of muscle relaxants.
TECHNIQUE
Electromyographic measurements of hypothenar muscle activity were used to assess the effect of decamethonium iodide on peripheral musculature and a mercury column ergometer used to measure grip strength. To analyse individual muscle action potentials co-axial needle electrodes (S.W.G.24) made of stainless steel with copper cores were used. Following detection the action potentials were amplified by a conventional high gain differential amplifier. The time constant of the amplifier was 0.1 per second and the frequency response was 6 decibels down at 1 6 cycles and 8 kilocycles. After amplification the potentials were recorded on magnetic tape (overall time constant 5 millisecs.). These recordings, which could be selected at will, were then displayed on a cathode-ray tube from which they were photographed.
For measurements of muscle power, supramaximal electrical stimulation of the ulnar nerve was effected at the wrist or elbow, and the total muscle action potential detected with skin electrodes. The skin electrodes were held in position by suction and contact made with electrode jelly. The resultant potential was displayed on a cathode-ray tube, photographed, enlarged, and finally its height measured ( Fig. 1 ). As the height of the potential diminished, due to the paralysing action of decamethonium, so the results were compared with the control value and expressed as a percentage degree of paralysis. Following recovery the action potential was compared with the control, and results were only acceptable if exact matching between the two action poten-tials was obtained. Thus technical errors due to movement of the skin electrodes were eliminated. Although a stimulation rate of 20 per second is more nearly that of normal motor unit activity, 10 per second was used in this investigation. In this way neuromuscular block due to myasthenia, which rapidly occurs at the rate of 20 per second, was avoided. It can be shown that, in contrast to curare, the rate of nerve stimulation does not alter the degree of neuromuscular block produced by decamethonium iodide in normals (Fig. 2) . Stimulation was carried out intermittently at two-minute intervals for 5 seconds. The duration of the electrical stimulus used was 0O3 millisecond and it was rendered earth free by a transformer. Such a short stimulus can only excite muscle via the nerve and cannot directly stimulate the muscle. In keeping with the results described by Organe (1949) , it was soon found that wide variations in the response to decamethonium iodide occurred and it was not possible to relate the dose of decamethonium iodide necessary to produce a constant degree of paralysis to the body-weight of conscious volunteers. A method involving a standard dosage was therefore necessary. Following the measurement of a control action potential each subject was given 1-5 mg. of decamethonium iodide intravenously. After an interval of four minutes, a further measurement was made and if there was less than a 50% reduction in height of the action potential then a further 0 5 mg. was given. This procedure was repeated at two-minute intervals until approximately a 60-80 % reduction in the action potential was produced, or in myasthenics distressing symptoms began to occur. An interval of four minutes was thought to be necessary if the full effect of the first dose was to be manifest before proceeding. Subsequently the intervals were reduced to two minutes so that all the injections were completed within fifteen minutes. This ensured that the initial dose was fully active before the investigation was complete. RESULTS
(1) Clinical signs and symptoms.-(a) Intravenous: The signs and symptoms following the injection of C 10 into conscious volunteers fell largely into two groups. The first group started 15-20 seconds after the injection and consisted of double vision, ptosis and squint. In some people a feeling of tightness in the jaw and calf muscles was experienced. Dysphagia and dysphonia followed a large dose (such as 3 mg.). These symptoms and signs started to disappear in two or three minutes in the same order as their onset.
The second group usually came on about four minutes after the injection as a rapidly increasing degree of paralysis shown by a reduction in grip strength and a reduction in the height of the muscle action potential. In fact, initially the bulbar musculature was mainly involved whereas the peripheral muscles seemed to be affected some minutes later.
(b) Intra-arterial: In addition to the technique using divided intravenous doses of decamethonium, some experiments with intra-arterial injections were carried out. It may be of interest to mention the effects of an intra-arterial injection since there does not seem to be any reference to this in the literature. A continuous injection of the brachial artery with a power-driven syringe was used. Two minutes after starting, the infusion at 10 micro-gramme/minute a dull deep ache developed, starting in the region of the needle and spreading rapidly down the arm. This dull feeling, occurring deep in the arm, increased in intensity until it became an unpleasant ache as the paralysis became complete. On stopping the infusion the pain passed off in about two minutes and recovery from the paralysis commenced in ten to twenty minutes. The time taken to return to normal depended largely on whether exercise was undertaken or not (vide infra).
(2) Site ofaction of decamethonium.-Electromyographic study showed that the initial depolarizing action of decamethonium iodide was accompanied by a shower of muscle action potentials. This was most readily demonstrated in denervated muscle where the muscle fibres are abnormally excitable (Zaimis, 1951) . Reference to Fig. 3 shows that stimulation of the intact motor unit distal to the point of branching of the nerve fibre would be expected to produce single muscle fibre potentials. However, stimulation of the lower motor neurone in this area may excite the entire motor unit. Similarly, if stimulation of the motor unit occurs above the point of branching of the lower motor neurone, it results in the contraction of all the fibres of the motor unit. Excitation of entire motor units results in a shower of whole motor unit potentials, as opposed to single muscle fibre potentials which occur if the muscle fibres are stimulated directly. (B).
When partial paralysis from neuromuscular block had occurred with decamethonium iodide the volitional motor unit potentials became smaller in amplitude and duration than normal. This change can only be produced by the failure of some of the muscle fibres constituting the motor unit to contribute their part of the motor unit potential and indicates a lesion distal to the point of branching of the lower motor neurone. In contrast, if paralysis occurred above this point it would result in inactivity of the entire motor unit (Fig. 4) . Following complete paralysis of voluntary muscle activity by decamethonium iodide, the muscles still respond to direct electrical stimulation. It is thus evident from this finding and the electromyographic changes in innervated and denervated muscles that the site of action of decamethonium is at the neuromuscular junction, as has been shown in the animal experiments that have been described.
(3) The effect of blood supply on the action of decamethonium iodide.-lt was observed in conscious volunteers that about twenty minutes after the injection of decamethonium iodide, although the ergometer showed that full motor power had returned to the upper limb, the subjects had extreme difficulty in walking. In fact it appeared that although the effects of the drug had worn off in the upper limb, the lower limbs were still partially paralysed. Further, if the subjects exercised their legs for a few minutes a rapid improvement in strength occurred. A study of the effect of exercise on the rate of recovery from paralysis induced by decamethonium iodide was obviously required to clarify these observations. Measurements of muscle power as registered by the electromyograph and ergometer were therefore made of the upper limbs while one limb was kept at rest and the other was exercised. It became evident that the duration of paralysis of muscles following decamethonium administration to conscious subjects at rest was considerably longer than twenty minutes (Fig. 5 ). In fact, the paralysis did not reach its maximum until about the twentieth minute after the injection, when the arm remained passive (Table I) .
It was necessary to determine why exercising a muscle should so alter the duration of paralysis following the injection of decamethonium iodide. Exercising a muscle undoubtedly increases the blood supply through it and this was thought to be a factor of the utmost importance. To investigate this various experiments were carried out:
(a) The effect of variation in temperature: One limb was heated by an infra-red lamp while the other limb was cooled with ice-bags. Electromyographic measurements were used, because unlike ergometric measurements these allowed the limbs to be almost completely at rest. It was observed that the heated limb showed a rapid onset and recovery of paralysis whereas the cooled limb showed a slow onset of paralysis which reached its maximum and remained at this level until the arm was heated (Fig. 6) . (b) The effect of ischamia: In this investigation, one subject was anesthetized with thiopentone, nitrous oxide and oxygen and an occlusion cuff applied to the arm after paralysis. It was already known that thiopentone in clinical doses did not affect neuromuscular transmission. 4 mg. of decamethonium iodide produced complete paralysis in both arms in three minutes. The control arm showed recovery in normal time but the occluded arm remained paralysed until the cuff was released. On the release of the cuff a marked hyperaemia occurred and the arm recovered 50 % of its motor power in three minutes (Fig. 7) . of 4% procaine at the elbow. Full motor and sensory paralysis was produced in each case, and therefore full sympathetic paralysis must have taken place. An increase in blood supply due to sympathetic paralysis was obtained and confirmed by recordings of the skin temperature. Electromyographic measurements of muscle power showed that following the injection of decamethonium iodide, the control arm had a typical response but the arm with the ulnar block had almost no paralysis (Fig. 8) . It was not anticipated that blocking of the ulnar nerve would have such a marked effect on the action of decamethonium iodide. Although increase in the blood flow obviously plays a very important part, it is possible that some other factor, as yet unknown, may also be involved.
.This effect is unlikely to be due to the presence of procaine in the circulation as it is not produced when a large subcutaneous depot of procaine is placed in the control arm. These findings require further investigation. As further evidence of the marked effect of ulnar nerve block on the paralysis induced by decamethonium a nerve block was carried out immediately after the onset of paralysis. The resulting hyperemia produced a rapid recovery from the paralysis whereas the control arm remained paralysed (Fig. 9) . From this evidence it seems clear that the duration of paralysis following decamethonium is largely related to the blood supply of the part being studied. The importance of this will be realized when it is recalled that the blood flow through a muscle during exercise may be over twenty times more than the flow during rest.
Although we have studied only one group of muscles throughout (those of the hypothenar eminence), the relation of the paralysis produced by decamethonium on this group of muscles to its blood supply suggests that the constantly active respiratory muscles should be the last to be affected and the first to recover. Guild (1950) , using an ergometer and cyclometer, states that his subjects recovered more quickly than those quoted by Organe (1949) who used an ergometer alone. It seems possible that Guild's subjects may have undertaken more strenuous exercise, resulting in an increase in muscle blood flow, and consequently a quicker recovery from the effects of C 10.
Again, Gray (1950) states that the use of decamethonium for long operations has been discontinued because of the occasional prolonged paralysis due to delayed detoxication. It has now been shown that the peripheral blood flow is greatly increased at the beginning of anaesthesia (Lynn and Shackman, 1951) . However, after the first hour the blood flow has returned to normal and later may be seriously reduced. It is thus possible to imagine that the use of decamethonium towards the end of a long abdominal operation with some degree of peripheral vasoconstriction may be followed by a very prolonged paralysis. In the event of continued respiratory depression it would seem theoretically sound to use the phrenic pulsator, since the resulting exercise should shorten the duration of paralysis. Paton and Zaimis (1950) have drawn attention to the danger of comparing the effects of muscle relaxants on the hand-grip muscles and the abdominal musculature. They have pointed out that the two different types of muscle (red and white) respond in different ways to this drug in animals. They also stressed the danger of using conscious volunteers, in whom adrenaline may alter the response of a particular muscle to the injection of decamethonium. We do not believe that the liberation of adrenaline significantly altered the response in our series of control subjects. Adrenaline increases the cardiac output and dilates the muscle vessels, thus increasing their blood supply; consequently, if adrenaline liberation affected our results it would have tended to shorten the duration of paralysis.
(4) The action of decamethonium iodide in myasthenia gravis.-Paton and Zaimis in their paper (1950) on the clinical assessment of drugs which produce neuromuscular block stated "it would be of great interest to know what the sensitivity of a myasthenic is to decamethonium, since it would not only determine whether idiosyncrasy of this kind occurred to decamethonium but would also throw light on the pathogenesis of myasthenia". In addition the possible use of decamethonium for the operation of thymectomy demands a full knowledge of the reaction of myasthenics to this drug.
Jn a series of 14 control subjects and 11 myasthenics Churchill-Davidson and Richardson (1952), using the above technique of administration and measurement, showed that none of the control subjects were able to tolerate 2 5 mg. of decamethonium without showing 60% or more paralysis of the hypothenar muscles as measured by the electromyograph, and indeed only one tolerated 2-0 mg. without showing a marked degree of paralysis. In contrast, the 11 cases of myasthenia gravis showed, with only one exception, a marked tolerance to the paralysing action of decamethonium iodide. This tolerance reached its extreme in one patient who after an injection of 10 mg. of decamethonium iodide showed no signs of a response. This case is more remarkable not only for the fact that it suggests a high degree of tolerance to decamethonium but that the depth of that tolerance has not yet been sounded.
If the only evidence of myasthenic weakness is drooping of the eyelids then that patient is more liable to withstand large doses of decamethonium than one with a more generalized weakness. However, when the limit of this tolerance is reached, it seems that the muscles first affected are those which show the greatest degree of myasthenic fatigue. It is in this fact that the danger of the administering of decamethonium to patients with myasthenia gravis lies, because no longer are the respiratory muscles necessarily the last to be paralysed. For example, one patient with severe myasthenia gravis was given 3 mg. of decamethonium, there being at this stage only a slight visual disturbance with hoarseness of the voice. Immediately after giving a further 0 5 mg. complete paralysis of sight, voice, swallowing and respiration ensued. However, the patient was still able to signal with his arms. In fact, electromyographic measurements showed an increase in the response of the hypothenar muscles. Thus, paradoxically, a patient with complete bulbar paralysis was not paralysed in his peripheral muscles (Fig. 10) .
The significance of these findings in myasthenia gravis from the anesthetist's viewpoint is that should a patient with latent or a subclinical degree of myasthenia receive a large dose of decamethonium iodide in error, then the response is unlikely to be as great as that of a normal subject. If the dose was great enough to paralyse the patient's respiratory muscles, however, then the evidence suggests that the duration of the respiratory paralysis would depend chiefly upon the rate of excretion of the decamethonium.
It is a pleasure to acknowledge the help we have received from Dr. P. Bauwens and Dr. M. D. No'worthvof St. Thomas's I4osnital-These fundamental differences result in the general situation that those conditions (summarized by which favour the action of d-tubocurarine lessen the action of decamethonium, and vice versa.
The possibility was, therefore, that a myasthenic, in whom, as we know, d-tubocurarine is peculiarly active, should not only fail to be abnormally sensitive to decamethonium, or even merely exhibit normal sensitivity, but should actually be more resistant to decamethonium than normal individuals. It is this point that Churchill-Davidson and Richardson have appreciated and demonstrated so convincingly. It must be added, of course, that there is likely to be a rather complex relationship between the intensity of the myasthenia and the sensitivity to decamethonium. If one can use the analogy of the partially curarized organism, then, in general, one would expect actual resistance to decamethonium to be most easily demonstrable in the milder cases of myasthenia.
It follows, then, as the authors have pointed out, that the end-plate of the myasthenic is resistant to depolarization. If myasthenia is not due to a circulating curarizing compound (and the curious incidence of its attack in the body is often extremely unlike the uniform picture to be expected with a blood-borne blocking agent), then one must suppose that there is in the muscle membrane at the end-plate some defect of the specific apparatus whereby the impact of minute amounts of acetylcholine arouses a potential change big enough to excitp the muscle fibre.
(2) The effects of changes in muscle blood flow on neuromuscular block by decamethonium are quite new and most important. I would like to know what would be the outcome of similar experiments with d-tubocurarine, and such experiments might well exclude some of the possible explanations. One suggestion may be ventured, however. As already mentioned, decamethonium causes a persisting depolarization of the end-plate, and with this depolarization (as with that of any other of the excitable membranes in the body) there will be a passage of potassium outwards. Now Hodgkin and Huxley (1947) , in early work on ion-movements, were able to measure the amount of potassium released by an action potential in a non-medullated nerve by enclosing the nerve in liquid paraffin, so that the potassium was released into the very thin film of saline left round the nerve and could accumulate in a concentration sufficient to alter the properties of the nerve membrane quite considerably. As soon as the nerve was rinsed in saline, these effects disappeared. I suggest that perhaps there is an analogous situation here. In the relatively avascular muscle, potassium accumulation in the environs of the depolarized end-plate must certainly be occurring, and might well accentuate the inexcitability of the membrane; whereas such accumulation would be much slighter in wellvascularized muscle. One can then explain one curious feature of their results, that procaine nerve block was a more effective antagonist than exercise. For muscular exercise, while increasing blood flow, will also itself cause the release of potassium from the muscle fibre, but the release of sympathetic constrictor tone by procaine block will not do this. The other aspects of these findings should make us look at many of the experimental results in a new light.
(3) The excitation of motor-unit activity may, I think, be attributed to an action described by Masland, and Wigton in 1940. They observed that the fasciculations seen in cats after the injection of Prostigmine were associated with impulses travelling antidromically up the motor nerve towards the ventral roots, and that these impulses were abolished by curare, but could also be obtained with acetylcholine. They excluded the possibilities that the effect was due to stimulation of the motor nerve endings by movements of the muscle, or to stimulation of the nerve trunk directly by these drugs, and verified that the impulses were running centripetally. Their tentative conclusion was that acetylcholine can stimulate nerve terminals as well as endplates, but this is somewhat uncertain.
Since acetylcholine, prostigmine and decamethonium are all so closely related in their actions at the endplate, one may accept very readily Churchill-Davidson and Richardson's conclusion that they have been observing synchronous discharges by motor units, and suggest that these discharges correspond to the Masland-Wigton phenomenon, in which excitation of some of the nerve terminations of the motor unit causes a centripetal antidromic impulse in the motor nerve axon and (by a sort of "axon reflex") a more or less synchronous discharge of the whole motor unit.
